Lucas is an R&D Manager at TCI Group, specialising in clinically validated probiotic solutions and liquid delivery systems for gut-axis health applications. He has led multiple human clinical studies on Weizmannia coagulans, with a focus on liver health, gastric balance and metabolic resilience. His work bridges strain-level microbiome science with consumer-friendly product formats, translating clinical evidence into innovative health solutions, including the world’s first shelf-stable probiotic chocolate gel.